CrewCrew
FeedSignalsMy Subscriptions
Get Started
Sleep Science and the Sleep Economy

Sleep Science and the Sleep Economy — 2026-10-10

  1. Signals
  2. /
  3. Sleep Science and the Sleep Economy

Sleep Science and the Sleep Economy — 2026-10-10

Sleep Science and the Sleep Economy|October 10, 2026(2h ago)3 min read8.3AI quality score — automatically evaluated based on accuracy, depth, and source quality
0 subscribers

This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.

The U.S. Senate faces a deadlock on making Daylight Saving Time permanent, impacting sleep health debates and school schedules. Meanwhile, new clinical trials for melatonin and daridorexant are reshaping insomnia treatment options, while Japan’s sleep-tech market continues its rapid expansion.

Sleep Science and the Sleep Economy — 2026-10-10


Top developments


Senate Deadlock Halts Permanent Daylight Saving Time

As Americans prepare to "fall back" on November 1, 2026, the push for permanent Daylight Saving Time (DST) has stalled in the Senate. Despite passing the House and receiving strong backing from President Trump, Senate Majority Leader John Thune stated there is "no clear path forward" for the Sunshine Protection Act due to internal GOP disagreements. This legislative uncertainty keeps the biannual clock change in place, a practice widely criticized by sleep experts for disrupting circadian rhythms.

Senate Majority Leader John Thune discusses the lack of clear path for permanent DST legislation
Senate Majority Leader John Thune discusses the lack of clear path for permanent DST legislation


New Clinical Evidence Boosts Melatonin and Daridorexant

A peer-reviewed trial published this week demonstrated that sustained-release melatonin at a 2 mg dose significantly improves sleep, adding objective polysomnography data to a previously self-report-heavy field. Concurrently, BioSpace reported that new Phase 2 results for daridorexant in pediatric insomnia will be presented at Sleep Europe 2026, marking the first investigational data for a dual orexin receptor antagonist in children. These developments signal a shift toward more rigorous, evidence-based interventions for both adult and pediatric sleep disorders.

Graphical representation of clinical trial results for daridorexant
Graphical representation of clinical trial results for daridorexant

biospace.com

biospace.com

static.biospace.com

static.biospace.com


Japan’s Sleep-Tech Market Hits 16 Billion Yen

Japanese media highlighted a seminar hosted by Pro Labo Holdings in Tokyo on October 7, discussing the rapid growth of the domestic sleep-tech sector. The market, valued at approximately 16 billion yen, is expanding as consumers seek non-pharmaceutical solutions for chronic sleep debt. The event showcased next-generation sleep and recovery devices, reflecting a broader trend where sleep improvement is treated as a critical social issue rather than just a lifestyle choice.

Attendees at the Tokyo sleep-tech seminar viewing recovery devices
Attendees at the Tokyo sleep-tech seminar viewing recovery devices


Wearable Sleep Tracker Market Forecast to Expand Through 2035

IndexBox released a new forecast indicating that the global wearable sleep trackers market will continue to accelerate through 2035. Growth is driven by rising consumer awareness of sleep health and the integration of advanced sensors into standard smartwatches, moving beyond niche fitness devices to mainstream health tools.


Local view

Japan Local stakeholders are increasingly framing sleep debt as a societal crisis requiring technological intervention. The "SLEEP ACTION LAB," a co-creation project launched by Brain Sleep, aims to bridge the gap between sleep knowledge and behavior, addressing the common issue of "late-night scrolling" despite awareness of its harms. This initiative highlights a shift from passive product consumption to active behavioral modification programs supported by tech.


Context & numbers

  • Hospitality Mattress Market: Projected to grow from USD 7.1 billion in 2025 to USD 12.8 billion by 2035, with a CAGR of 6.0%.
  • DST Deadline: Clocks will fall back one hour at 2 a.m. on Sunday, November 1, 2026, barring any last-minute legislative changes.
  • Melatonin Regulation: Continued concerns persist regarding the lack of FDA full regulation for melatonin supplements, with calls for stricter testing of gummy bear products.

On the radar

  • Sleep Europe 2026: Upcoming presentations on pediatric insomnia data for daridorexant are expected to draw significant attention from regulators and clinicians.
  • November Clock Change: The immediate impact of the November 1 time change on sleep quality metrics and workplace productivity will likely dominate US media coverage in late October.

This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.

Explore related topics
  • QWhy is the Senate divided on permanent DST?
  • QWhat are the side effects of daridorexant?
  • QWhich sleep-tech devices are leading in Japan?

Powered by

CrewCrew

Sources

Want your own AI intelligence feed?

Create custom signals on any topic. AI curates and delivers 24/7.